title: Non-conventional therapeutics for oral infections.
abstract: As our knowledge of host-microbial interactions within the oral cavity increases, future treatments are likely to be more targeted. For example, efforts to target a single species or key virulence factors that they produce, while maintaining the natural balance of the resident oral microbiota that acts to modulate the host immune response would be an advantage. Targeted approaches may be directed at the black-pigmented anaerobes, Porphyromonas gingivalis and Prevotella intermedia, associated with periodontitis. Such pigments provide an opportunity for targeted phototherapy with high-intensity monochromatic light. Functional inhibition approaches, including the use of enzyme inhibitors, are also being explored to control periodontitis. More general disruption of dental plaque through the use of enzymes and detergents, alone and in combination, shows much promise. The use of probiotics and prebiotics to improve gastrointestinal health has now led to an interest in using these approaches to control oral disease. More recently the potential of antimicrobial peptides and nanotechnology, through the application of nanoparticles with biocidal, anti-adhesive and delivery capabilities, has been explored. The aim of this review is to consider the current status as regards non-conventional treatment approaches for oral infections with particular emphasis on the plaque-related diseases.
authors: a Oral Microbiology; Barts and The London School of Medicine & Dentistry; Queen Mary University of London ; London, UK.
authors: Robert P
authors: RP
authors: Allaker
authors: C W
authors: CW
authors: Ian Douglas
mesh_terms: D000818:Animals; D001421:Bacteria, Anaerobic / Q000472:pathogenicity; D003773:Dental Plaque / Q000382:microbiology / Q000628:therapy*; D003902:Detergents / Q000627:therapeutic use; D006026:Glycoside Hydrolases / Q000627:therapeutic use; D006801:Humans; D009055:Mouth / Q000382:microbiology*; D053758:Nanoparticles; D010518:Periodontitis / Q000628:therapy*; D010789:Phototherapy; D016966:Porphyromonas gingivalis / Q000472:pathogenicity; D056692:Prebiotics; D018713:Prevotella intermedia / Q000472:pathogenicity; D019936:Probiotics / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use
chemical_list: D003902:Detergents; D056692:Prebiotics; D011480:Protease Inhibitors; D006026:Glycoside Hydrolases
keywords: antimicrobial peptides; caries; detergents; enzymes; light-activation; nanoparticles; periodontitis; probiotics